EAM

Exome Asset Management Portfolio holdings

AUM $202M
1-Year Est. Return 151.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+151.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$202M
AUM Growth
+$51M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$5.81M
2
+$4.8M
3
+$4.43M
4
WVE icon
Wave Life Sciences
WVE
+$4.28M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.06M

Top Sells

1
+$8.17M
2
+$4.16M
3
+$4.02M
4
COGT icon
Cogent Biosciences
COGT
+$3.88M
5
APGE icon
Apogee Therapeutics
APGE
+$3.75M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
51
Establishment Labs
ESTA
$2.09B
$955K 0.47%
13,100
RAPT
52
DELISTED
RAPT Therapeutics
RAPT
$481K 0.24%
+14,194
ABUS icon
53
Arbutus Biopharma
ABUS
$904M
$363K 0.18%
75,484
ACAD icon
54
Acadia Pharmaceuticals
ACAD
$3.82B
– –
0
AKRO
55
DELISTED
Akero Therapeutics
AKRO
– –
-58,579
ALDX icon
56
Aldeyra Therapeutics
ALDX
$280M
– –
0
APGE icon
57
Apogee Therapeutics
APGE
$4.85B
– –
-94,400
ARCT icon
58
Arcturus Therapeutics
ARCT
$206M
– –
0
AVTX icon
59
Avalo Therapeutics
AVTX
$325M
– –
-100,036
CNTA
60
Centessa Pharmaceuticals
CNTA
$3.89B
– –
-88,024
COR icon
61
Cencora
COR
$69.9B
– –
-6,000
CVS icon
62
CVS Health
CVS
$100B
– –
-43,600
ETNB
63
DELISTED
89bio
ETNB
– –
-273,661
GERN icon
64
Geron
GERN
$906M
– –
-1,858,354
IMUX icon
65
Immunic
IMUX
$134M
– –
-173,900
INSP icon
66
Inspire Medical Systems
INSP
$1.79B
– –
-18,600
MLTX icon
67
MoonLake Immunotherapeutics
MLTX
$1.29B
– –
-178,084
NVO icon
68
Novo Nordisk
NVO
$174B
– –
0
ORIC icon
69
Oric Pharmaceuticals
ORIC
$1.55B
– –
-120,644
PGEN icon
70
Precigen
PGEN
$1.19B
– –
0
PPH icon
71
VanEck Pharmaceutical ETF
PPH
$1.24B
– –
0
PRCT icon
72
Procept Biorobotics
PRCT
$1.43B
– –
-39,900
QURE icon
73
uniQure
QURE
$663M
– –
-22,090
RARE icon
74
Ultragenyx Pharmaceutical
RARE
$2.07B
– –
0
REPL icon
75
Replimune Group
REPL
$581M
– –
-73,614
1 2
3
4